JW Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
₩394.19B ₩401.62B ₩342.77B ₩385.01B ₩437.65B ₩455.15B ₩443.28B ₩431.01B ₩397.08B ₩394.18B ₩412.79B ₩434.35B ₩467.47B ₩502.92B ₩537.18B ₩511.34B ₩547.34B ₩606.58B ₩684.35B ₩748.53B ₩0.00M
GM % Gross Margin %
42.80% 43.49% 48.33% 47.82% 43.99% 41.06% 36.51% 34.34% 32.48% 36.65% 36.65% 36.98% 37.08% 37.51% 36.68% 31.51% 32.43% 38.64% 42.08% 44.83% 0.00%
OM Operating Margin
11.26% 10.13% 13.73% 10.72% 8.38% 8.17% 5.79% 4.07% 2.39% 6.57% 3.21% 4.96% 5.25% 4.32% 4.02% -3.72% -0.24% 5.09% 8.84% 12.91% 0.00%
EPS Earnings Per Share
₩-630.44 ₩298.78 ₩1.30k ₩1.53k ₩0.00
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩239.54 ₩0.00 ₩0.00 ₩0.00 ₩367.65 ₩362.91 ₩0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 80.17% 0 0 0 28.17% 23.74% 0
Sha. Shares
19.19m 18.21m 18.25m 18.16m 13.78m 13.81m 13.81m 13.94m 15.12m 17.44m 17.78m 20.47m 20.46m 19.97m 20.7m 20.84m 22.77m 21.45m 22.08m 0m 23.33m
OCF Operating Cash Flow
₩15.02B ₩70.25B ₩30.53B ₩14.82B ₩-1348.00M ₩-11118.76M ₩-9811.91M ₩-18183.74M ₩63.20B ₩18.72B ₩7.28B ₩-4174.93M ₩6.74B ₩33.45B ₩52.11B ₩55.53B ₩63.05B ₩18.12B ₩56.76B ₩87.16B ₩0.00M
FCF Free Cash Flow
₩-12466.30M ₩-27507.56M ₩21.10B ₩2.43B ₩-34770.49M ₩-73711.17M ₩-40113.61M ₩-28018.80M ₩47.86B ₩14.44B ₩350.15M ₩-9731.37M ₩-1406.75M ₩25.95B ₩44.41B ₩46.25B ₩50.67B ₩10.66B ₩46.85B ₩3.05B ₩0.00M
FCFS Free Cash Flow Per Share
₩-1073.92 ₩-1781.92 ₩898.41 ₩-62.51 ₩-2835.07 ₩-5754.63 ₩-3256.35 ₩-2896.76 ₩3.30k ₩540.50 ₩-316.34 ₩-681.25 ₩-171.56 ₩2.30k ₩1.79k ₩1.97k ₩2.24k ₩236.41 ₩1.91k ₩1.01k ₩0.00